Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts

  1. Messersmith, W.A.
  2. Rajeshkumar, N.V.
  3. Aik, C.T.
  4. Xiao, F.W.
  5. Diesl, V.
  6. Choe, S.E.
  7. Follettie, M.
  8. Coughlin, C.
  9. Boschelli, F.
  10. Garcia-Garcia, E.
  11. Lopez-Rios, F.
  12. Jimeno, A.
  13. Hidalgo, M.
Revue:
Molecular Cancer Therapeutics

ISSN: 1535-7163

Année de publication: 2009

Volumen: 8

Número: 6

Pages: 1484-1493

Type: Article

DOI: 10.1158/1535-7163.MCT-09-0075 GOOGLE SCHOLAR